186 related articles for article (PubMed ID: 35915245)
1. Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling.
Liu Q; You B; Meng J; Huang CP; Dong G; Wang R; Chou F; Gao S; Chang C; Yeh S; Xu W
Cancer Gene Ther; 2022 Dec; 29(12):1988-2000. PubMed ID: 35915245
[TBL] [Abstract][Full Text] [Related]
2. Androgen Receptor Transcriptionally Inhibits Programmed Death Ligand-1 Expression and Influences Immune Escape in Bladder Cancer.
Sun A; Luo Y; Xiao W; Zhu Z; Yan H; Miao C; Zhang W; Bai P; Liu C; Yang D; Shao Z; Song J; Wu Z; Chen B; Xing J; Wang T
Lab Invest; 2023 Jul; 103(7):100148. PubMed ID: 37059268
[TBL] [Abstract][Full Text] [Related]
3. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.
Deng G; Wang R; Sun Y; Huang CP; Yeh S; You B; Feng C; Li G; Ma S; Chang C
Cell Death Differ; 2021 Jul; 28(7):2145-2159. PubMed ID: 34127806
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion.
Chen J; Sun Y; Ou Z; Yeh S; Huang CP; You B; Tsai YC; Sheu TJ; Zu X; Chang C
EMBO Rep; 2020 Apr; 21(4):e48467. PubMed ID: 32052578
[TBL] [Abstract][Full Text] [Related]
5. N
Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression.
Mao W; Huang X; Wang L; Zhang Z; Liu M; Li Y; Luo M; Yao X; Fan J; Geng J
J Exp Clin Cancer Res; 2019 Apr; 38(1):169. PubMed ID: 30999937
[TBL] [Abstract][Full Text] [Related]
7. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis.
Gao C; Xu YJ; Qi L; Bao YF; Zhang L; Zheng L
Cell Biol Toxicol; 2022 Oct; 38(5):825-845. PubMed ID: 34018092
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression.
Yang C; Yuan W; Yang X; Li P; Wang J; Han J; Tao J; Li P; Yang H; Lv Q; Zhang W
Mol Cancer; 2018 Jan; 17(1):19. PubMed ID: 29386015
[TBL] [Abstract][Full Text] [Related]
9. ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion.
Wu L; Zhang M; Qi L; Zu X; Li Y; Liu L; Chen M; Li Y; He W; Hu X; Mo M; Ou Z; Wang L
Cell Death Dis; 2019 Aug; 10(9):635. PubMed ID: 31455760
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
[TBL] [Abstract][Full Text] [Related]
11. Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway.
Xu YJ; Zhao JM; Gao C; Ni XF; Wang W; Hu WW; Wu CP
Cell Signal; 2021 Oct; 86():110095. PubMed ID: 34320370
[TBL] [Abstract][Full Text] [Related]
12. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
Zhang J; Zhou Q; Xie K; Cheng L; Peng S; Xie R; Liu L; Zhang Y; Dong W; Han J; Huang M; Chen Y; Lin T; Huang J; Chen X
J Exp Clin Cancer Res; 2021 Jun; 40(1):203. PubMed ID: 34154613
[TBL] [Abstract][Full Text] [Related]
13. Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis.
Fan L; Yang J; Shen C; Wu Z; Hu H
Acta Histochem; 2021 Jul; 123(5):151745. PubMed ID: 34175686
[TBL] [Abstract][Full Text] [Related]
14. Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint.
Lei J; Zhu J; Hui B; Jia C; Yan X; Jiang T; Wang X
Cancer Immunol Immunother; 2023 Jan; 72(1):101-124. PubMed ID: 35750765
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
Wei S; Wang K; Huang X; Zhao Z; Zhao Z
Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA_0001495 increases Robo1 expression by sponging microRNA-527 to promote the proliferation, migration and invasion of bladder cancer cells.
Feng L; Fu D; Gao L; Cheng H; Zhu C; Zhang G
Carcinogenesis; 2021 Aug; 42(8):1046-1055. PubMed ID: 34021307
[TBL] [Abstract][Full Text] [Related]
17. Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks.
Xu Y; Sun X; Liu G; Li H; Yu M; Zhu Y
Front Immunol; 2023; 14():1301157. PubMed ID: 38299148
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.
Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q
Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR-138 targets TERT and PD-L1.
Zhang XL; Xu LL; Wang F
Cell Biol Int; 2017 Sep; 41(9):1056-1064. PubMed ID: 28707774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]